Breaking News

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) insiders have a reason to boast after seeing a US$2.0m addition to their US$4.9m investment

Vertex Prescribed drugs Integrated (NASDAQ:VRTX) insiders who purchased shares above the earlier 12 months were rewarded handsomely previous week. The stock rose 5.7%, ensuing in a US$3.8b increase in the firm’s current market capitalisation. As a outcome, the inventory they originally acquired for US$4.9m is now well worth US$6.9m. Although insider transactions are not the […]